These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 10464845

  • 1. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
    Ayres JG, Simmons JL, Stampone P.
    Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
    [Abstract] [Full Text] [Related]

  • 2. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
    Thompson PJ, Davies RJ, Young WF, Grossman AB, Donnell D.
    Respir Med; 1998 Jun; 92 Suppl A():33-9. PubMed ID: 9850361
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [Abstract] [Full Text] [Related]

  • 4. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
    Davies RJ, Stampone P, O'Connor BJ.
    Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ.
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [Abstract] [Full Text] [Related]

  • 6. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
    Juniper EF, Buist AS.
    Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
    [Abstract] [Full Text] [Related]

  • 7. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R, Ringdal N, Ward SM, Stampone P, Donnell D.
    Br J Clin Pract; 1997 Nov; 51(1):11-5. PubMed ID: 9158265
    [Abstract] [Full Text] [Related]

  • 8. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
    Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, Donnell D, Hannon S, Colice GL.
    J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
    [Abstract] [Full Text] [Related]

  • 9. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD, Walters EG.
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [Abstract] [Full Text] [Related]

  • 10. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
    Milanowski J, Qualtrough J, Perrin VL.
    Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
    [Abstract] [Full Text] [Related]

  • 11. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
    Donnell D, Harrison LI, Ward S, Klinger NM, Ekholm BP, Cooper KM, Porietis I, McEwen J.
    Eur J Clin Pharmacol; 1995 Apr; 48(6):473-7. PubMed ID: 8582466
    [Abstract] [Full Text] [Related]

  • 12. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
    Seale JP, Harrison LI.
    Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
    [Abstract] [Full Text] [Related]

  • 13. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
    Vondra V, Sladek K, Kotasová J, Terl M, Rossetti A, Cantini L.
    Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
    [Abstract] [Full Text] [Related]

  • 14. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C, Guerriero M, Tognella S, Dal Negro RW.
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [Abstract] [Full Text] [Related]

  • 15. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
    Wolthers OD.
    Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
    [Abstract] [Full Text] [Related]

  • 16. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
    Jacobson K, Chervinsky P, Noonan M, Kane RE, Banerji D, Uryniak T.
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
    [Abstract] [Full Text] [Related]

  • 17. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
    Anderson PB, Langley SJ, Mooney P, Jones J, Addlestone R, Rossetti A, Cantini L.
    J Investig Allergol Clin Immunol; 2002 Oct; 12(2):107-13. PubMed ID: 12371526
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 micrograms day-1 delivered as an extrafine aerosol in adults with moderate asthma.
    Matthys H, Nowak D, Hader S, Kunkel G.
    Respir Med; 1998 Jun; 92 Suppl A():17-22. PubMed ID: 9850359
    [Abstract] [Full Text] [Related]

  • 19. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A, Williams A, Batty L, Masterson C, Rossetti A, Cantini L.
    J Aerosol Med; 2002 Jun; 15(4):407-14. PubMed ID: 12581507
    [Abstract] [Full Text] [Related]

  • 20. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
    Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J.
    Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.